Tremendous work has demonstrated the critical roles of genetics, epigenetics as well as their interplay in brain transcriptional regulations in the pathology of schizophrenia (SCZ). There is great success currently in the dissection of the genetic components underlying risk-conferring transcriptomic networks. However, the study of regulating effect of epigenetics, as a modulator of environmental factors, in the etiopathogenesis of SCZ still faces many challenges. In this work we investigated DNA methylation and gene expression from the dorsolateral prefrontal cortex (DLPFC) region of schizophrenia patients and healthy controls using weighted correlation network approaches. We identified and replicated two expression and two methylation modules significantly associated with SCZ. Among them, one pair of expression and methylation modules were significantly overlapped in the module genes which were enriched in astrocyte-associated functional pathways, and specifically expressed in astrocytes. Another two linked expressionmethylation module pairs were involved aging process with module genes mostly related to oligodendrocyte development and myelination, and specially expressed in oligodendrocytes.
Introduction
Schizophrenia (SCZ) is known to be a highly heritable and developmental neuropsychiatric disorder, which has around 1% prevalence worldwide [1, 2] . In previous neuroimaging studies, SCZ has been characterized by brain-wide gray matter reduction [3] , functional disconnectivity [4, 5] and myelination decrease [6, 7] along with significant impairments in cognition [8] , and presence of positive and negative symptoms. These brain abnormalities are thought to be mediated by complex molecular processes involving neuronal cell development, differentiation and death, even during the early stage of brain development [9] . Despite substantial efforts on exploring the underlying molecular mechanisms through advanced genomics, epigenetics and transcriptomics techniques, there are still many challenges given the complex interplay among these factors for the etiology of SCZ.
Brain transcriptomics studies have demonstrated substantial transcriptional alterations in the frontal cortex, cerebellum or hippocampus of SCZ [10] . Keeping gene expression in balance is critical in maintaining neuronal function, as well as their synaptic interactions. Genetics is a major factor in regulating gene expression and functional pathways [11, 12] . Recent landmark work based on dorsolateral prefrontal cortex (DLPFC) postmortem tissue RNA sequencing has five neural cell type proportions estimation were also applied using the same algorithms as used in discovery data analysis.
Methylation replication dataset2 (MethyRep2; GSE36194): corresponding to expression replication dataset 1, methylation data from the same tissue of same subjects were profiled using with the Illumina Infinium HumanMethylation27K beadchip. The methylation data were preprocessed and quality controlled through the same steps as in discovery data analysis, resulting 26424 CpGs from 330 subjects for validation analysis.
Replication for modular's disease and age relatedness:
For those modules with ME vectors significantly associated with diagnosis, we validated the associations in the independent datasets.
For expression modules, we used ExpRep2 to select the probes from the same genes as the probes in the module and calculated the first PC of expression data for testing their associations with disease and age. A similar validation was applied for each significant methylation modules in MethyRep1. Replication significance level was set as 0.05.
Replication for module preservation:
Three different measures were applied to validate if the properties of selected modules were preserved across different datasets. First, a local clustering coefficient is a normalized average number of all triangle connections associated with each node.
The generalized clustering coefficient (GCC) by [47] for weighted network, accounting for weight information in each edge, was used to reflect the presence of the module structure and mean prevalence of connectivity around the nodes. A permutation test was applied to test the significance of GCC in replicated datasets. In each of 10 5 runs, we randomly selected features (expression probes or methylation sites) from the entire set and calculated GCC to build the null distribution. P-value can be derived by the proportion of runs with larger GCC than the observed GCC. Second, a composite preservation statistic was previously proposed to combine the measures of module density preservation (i.e. to test if the connections in the module remain in an independent dataset) and module connectivity preservation (to test if the connectivity pattern is similar to that in the independent dataset) and tested in [48] . A permutation was performed to estimate the mean and variance of each measure (i.e., module density and module connectivity) under the null hypothesis that there was no preservation of module in the measures, followed by the standardization of each observed measure to the mean and variance under null distribution, denoted by Z_density and Z_connectivity, respectively. The composite preservation statistic, denoted by Z_summary, was defined as the average of Z_density and Z_connectivity.
Z_summary < 2 indicates no preservation, 2<Z_summary<10 indicates weak to moderate evidence of preservation, while Z_summary>10 indicates strong evidence [48] . The p-value of the composite statistic was the combination of p values of module density and module connectivity.
Probe-level expression-methylation relation
To test directly regulation relation between expression and methylation at probe level for the linked modules, we leveraged the data from ExpRep1 and MethyRep2 that were collected from the same samples, and tested pair-wise associations of expression probes and methylation sites if they are located within 500k bps, using linear regression controlling for covariates age, sex and PMI.
Neural cell type and functional enrichment
To understand the cell specificity of each expression and methylation modules, we tested their enrichment in the genes expressed specifically in five cell types (neuron, astrocytes, microglia, endothelia cells, and oligodendrocytes using the pSI R package [49] with Fisher's exact test threshold as 0.05 and false discovery rate (FDR) as 0.05. The purified cell expression data from GSE73721 were used for the test [50] .The overlap of our modules with those cell-specific modules identified in a recent transcriptional study for psychiatric disorders [51] was also evaluated by Fisher's exact test. In addition, methylation data of both neuron and glia cells from postmortem prefrontal tissues of 29 control subjects (GSE41826 [52] ) were used to extract two sets of CpGs showing significant hyper-methylation in neuron (denoted by "neuron-up') and glia cells (denoted by "glia-up"), respectively (p<1×10 -10 ). These two sets of CpGs were then used to test the CpG overlap with identified methylation modules. To understand the biological function of each module, we performed a gene ontology (GO) and KEGG enrichment analysis on the genes in the module using the web tool Webgestalt (http://www.webgestalt.org/option.php).
Psychiatric disorders GWAS risk loci enrichment
Public meQTL database (GSE74193) and eQTL databases (GTeX: https://gtexportal.org/home/;
BrainSeq: http://eqtl.brainseq.org/phase1/devel) from brain DLPFC tissue were applied to access the genetic effects underlying expression and methylation networks. To test if the QTLs from target modules were significantly enriched in genetic risk loci of psychiatric disorders compared to the QTLs from the other modules, we adopted both Fisher's exact test and permutation test as applied in [29] . Specifically, we firstly ran linkage disequilibrium (LD) pruning supervised by GWAS risk loci on the whole QTL set with r 2 >0.7 using LD structure from 1000 genome project EUR group as reference. After pruning, the proportion of QTLs from the target module showing GWAS risk was taken as the observation. Then we generated null distribution by randomly sampling 10 5 sets of QTLs from the whole pruned QTL set with the same number of QTLs and similar minor allele frequency distribution as those from the target module. Empirical p-value was computed by the percentage of sampled QTL sets having higher proportion than the observed proportion, denoted by P_perm. Fisher's exact test was used to test the odds ratio of risk loci in target module QTLs and the QTLs from the other modules, denoted by P_Fisher.
Results

Co-expression modules and their associations with SZ
We clustered expression probes into 22 modules using WGCNA software with the dendrogram plot as shown in Fig.1A . The eigengenes of each module were tested for association with multiple traits as shown in Fig.1B . Two modules colored by magenta (including 276 probes) and yellow (including 1098 probes) were identified to have significant associations with SCZ diagnosis (yellow: t-stat = 4.1, p = 2×10 -3 ; magenta: t-stat = 3.55, p =9.7×10 -3 ) after controlling for covariates and correction for multiple tests by false positive rate (FDR). For each SCZ related module, we tested the correlation between module membership and SCZ group significance for all probes within the module, as shown in Fig.S1 A-B (Supplementary file 1). It can be seen that the correlation is significant in both modules with values of 0.53 and 0.28, respectively, showing that the probes with higher disease association tend to be more important in representing the module.
Independent validations were applied to verify both SCZ-related modules in two datasets (ExpRep1 and ExpRep2). In ExpRep1 dataset, 90.8% of expression probes from the yellow module and 88.8% probes from the magenta module were identified for replication. By permutation tests, we found that both modules were well preserved with significantly larger GCC than random selection of probes (p<1×10 -4 , Fig.S3 A-B) and higher Z_summary statistics (yellow module: Z = 38; magenta module: Z = 18, Fig.S1 C). As recommended in [48] , if Z_summary >10, there is strong evidence that the module is preserved. In ExpRep2 dataset, 72.6% genes from the yellow module and 73.3% genes from the magenta module were identified. The expressions of those probes from the matched genes were used to calculate the first eigenvector for each module as module eigengene, followed by a test for schizophrenia association. We replicated significant disease associations of both modules with the same direction as identified in the discovery dataset (yellow module: t-stat = 2.54, p = 0.014; magenta module: t-stat =2.68, p = 9.6×10 -3 ). In addition, both modules consistently showed significantly larger GCC in ExpRep2 data (p<1×10 -4 , Fig.S3 C-D).
Several co-expression modules were significantly enriched in different neural cell types.
For example, yellow expression module contains the genes mostly expressed in astrocytes while blue module is more specifically expressed in oligodendrocytes as shown in Fig.1C . Gene ontology enrichment analysis identified significant enrichment of genes from the yellow module in the pathways mainly involved the cell growth, migration, differentiation, movement, and organ development and morphogenesis as shown in Fig.1D (FDR<0.05). Interestingly, they were also highly enriched in some neurodevelopment pathways such as gliogenesis, glial and astrocyte cell differentiation and central nervous system development. From Fig.1E , it can be seen that genes in the magenta module were mostly involved in the inflammatory response to external stimulus (e.g., cytokine and lipopolysaccharide), and were more specifically expressed in endothelial and microglia cells. Besides these modules, several others were also found to have significant enrichment in the cell-specific co-expression modules reported in a previous study [51] , as shown in Fig.S4 . which are specific to neural cells (i.e., neuron, endothelial, astrocyte ,microglia and oligodendrocyte). (D) and (E) plot the network for the top 20 hub genes and their functional enrichment in gene ontology for magenta and yellow modules, respectively.
Methylation modules and their associations with SZ
By a similar network analysis, we identified 13 methylation modules and tested the associations of these module eigengenes with multiple traits as shown in Fig.2A . There were three modules colored by yellow (641 CpGs, t-stat = -7.22, p =6.6×10 -11 ), green (475 CpGs, t-stat = 3.78, p =7.5×10 -4 ) and turquoise (15983 CpGs, t-stat = -2.87, p = 0.01) showing significant relationship with schizophrenia diagnosis (FDR<0.05). In each of three modules, CpGs tended to have more significant SCZ vs. HC group differences if they demonstrated higher membership within the module (correlations were 0.91, 0.61 and 0.43, respectively, Fig.S2 A-C). Fig.2C -D show the network structure of top 20 genes with high module membership in yellow and green modules.
The genes from yellow module were significantly enriched in the functional pathways for developmental growth, axonogenesis, neurogenesis and neuron generations, while the genes from green module were related to cell projection, as shown in Fig.2C . Although genes in the turquoise module were also enriched in some neural development pathways such as forebrain development and central nervous system neuron differentiation, it had a large module size with less focus on specific functions and therefore was not further analyzed in this study. By matching the methylation nearby genes (<5kbp) with those from cell specifically expressed genes, we found strong enrichment of blue and red methylation modules in oligodentrocytes as shown in Fig.2B . Based on CpG patterns specific to neuron andglia cells, we identified that CpGs from blue and red methylation modules were more likely hypo-methylated in glia cells compared to neurons in human brain.
To validate the above results in MethyRep1 data, we matched 95.48% of CpGs in yellow module and 97.47% of CpGs in green module. We did not find any significant group difference in the first eigengene of yellow module (P = 0.28) but we found that the second eigengene showed group differences (t = -2.42, P = 0.02). The disease association for green module was significantly replicated with t = 2.98, P = 7.1×10 -3 . In addition, both modules were well preserved in the independent dataset with significantly higher GCC (P< 1×10 -4 , Fig 
Overlap between expression and methylation modules
After annotating methylation sites and expression probes to their target gene ensemble IDs, we tested the overlap among the expression and methylation modules based on both Fisher's test (i.e. FDR_Fisher) and permutation test (i.e. FDR_perm). As shown in Fig.S5 (Supplementary file 1), we identified three sets of significantly overlapped modules which can be grouped to two categories: SCZ-related and age-related overlapping sets.
The SCZ-related overlapping set included the yellow expression module and yellow methylation module (odds ration OR = 1.75, FDR_Fisher = 0.04, FDR_perm = 0.009). Both modules were significantly associated with SCZ disease as shown in Fig.1B and Fig.2A . There were 1109 expression probes (nearby 893 genes; Supplementary file 2) and 641 CpGs (nearby 591 genes; Supplementary file 3) from each module, respectively, with 5.2% probes located closely (<5kbp) to 9.5% CpGs, denoted by 'overlap CpGs' and 'overlap probes'. As shown in Fig.S6 (Supplementary file 1), overlap probes and CpGs were mainly involved the genes enriched in GO terms of regulating nitrogen compound metabolic process, biosynthetic process and fatty acid oxidation (FDR<0.05) and some interesting KEGG pathways like Wnt signaling, Adipocytokine signaling and Glutamatergic synapse(FDR<0.15). By annotating each CpG to its nearest gene, we found that 17.9% (p = 1.3×10 -3 ) of CpGs were located within 100kbp of TSS of genes from the expression module, while 41.5% (p = 2.2×10 -3 ) were within 500kbp, as shown in the density plot Fig.3A . Compared to those CpGs not included in the module, the overlap CpGs and the module CpGs(i.e., non-overlapped CpGs in the module) were significantly enriched in CpG islands (CGI) north shore (odds ratio: OR = 1.38 and 1.72), south shore (OR = 1.5 and 1.36), TSS200 regions (OR = 1.17 and 1.24), and 5UTR (OR = 1.34 and 2.18) as shown in Fig.3B .
From previously reported eQTL and meQTL findings, we found that 32.8% of CpGs in the module (including 32% of overlap CpGs) were modified by cis-meQTLs, while 74% of expression probes (including 95.7% of overlap probes) were regulated by cis-eQTLs. And 12.6% of the cis-meQTLs are also cis-eQTLs for the expression module. In particular, 36.3% of cis-meQTLs modifying overlap CpGs, were also cis-eQTLs. In addition, 13 out of total 205 proteincoding genes in the methylation module were located in 108 SCZ risk regions [53] as listed in Table S1 . The eQTLs also showed significant enrichment in risk loci of SCZ (OR = 1.31, p_perm <1×10 -5 ; p_Fisher = 9.6×10 -11 ) and three other psychiatric disorders (Autism spectrum disorder (ASD), Attention-deficit/hyperactivity disorder (ADHD) and dipolar disorder (BIP) ) as shown in Fig.3C . None significant enrichment was found for meQTLs in any psychiatric disorders.
Two age-related overlapping sets were found. One was between the blue expression module and the blue methylation module (OR = 2.39, FDR_Fisher = 1×10 -39 , FDR_permutation <1×10 -5 ), namely 'blueExp-blueMethy' link. The other was between the blue expression module and the red methylation module (OR = 5.79, FDR_Fisher =1×10 -30 , FDR_permutation <1×10 -5 ), namely 'blueExp-redMethy' link. The blue expression module has a negative association with age as shown in Fig.1B (partial η 2 = 0.025, p = 9.6×10 -3 ) and the association was replicated in ExpRep1 (89.6% probes included, p = 8.4×10 -3 ) and ExpRep2 (61.2% genes included, p = 4×10 -3 ). The blue and red methylation modules were also negatively significantly associated with age as shown in Fig.2A (blue: partial η 2 = 0.19, p = 1.2x10 -11 ; red: partial η 2 = 0.49, p = 2.5×10 -36 ) and the age-methylation associations were also replicated (blue module: 96.6% CpGs included, p = 0.016; red module: 97% CpGs included, p = 2.3×10 -6 ) in MethyRep1. GO term enrichment analysis showed that genes overlapped by blueExp-blueMethy modules were mainly enriched in functional pathways involving glial cell differentiation, gliogenesis, neurogenesis, axon ensheathment, and myelination ( Fig.S7 (A) ). Similar pathways were also significantly enriched by the overlapped genes from blueExp-redMethy linked modules, as shown in Fig.S7 (B) .
In blueExp-blueMethy link, there are 2317 expression probes and 6308 CpGs with 20.9%
CpGs located nearby 25.8% gene TSS (<5kbps). Fig.3D plots the distance distribution between CpGs and their nearest expression probes in the linked modules, showing that 36.4% CpGs were located within 100kbps of gene TSS and 65.5% CpGs were located within 500kbps. The overlap CpGs and module CpGs were mostly enriched in body of the gene and enhancer regions (OR = 1.77, p = 8.1×10 -100 and OR = 1.85, p = 1.4×10 -107 , respectively) compared to all other CpGs, as shown in Fig.3E . In addition, 42.2% of CpGs from the module including 40.2% of overlap CpGs were significantly modified by cis-meQTLs, while 73.3% of expression probes including 94.9% of overlap probes were affected by cis-eQTLs. In particular, 46.2% of the cis-meQTLs are also cis-eQTLs for the expression module. Fig3.F shows the significance of eQTLs enriched in risk loci of SCZ, BIP, ADHD and ASD but none significant enrichment was found for meQTLs in any psychiatric disorders.
In the red methylation module (440 CpGs) which was also overlapped with blue expression module as shown in Fig.S8 , 41.3% CpGs located closed to 5.4% of the expression gene TSS (<5kbps). 54.5% CpGs and 75.6% CpGs were located within 100kbps and 500kbps of TSS of genes from the expression module, respectively. CpGs from the red methylation module were significantly enriched in gene body (OR = 1.7, p = 1.5×10 -7 ) and enhancer regions (OR = 2.8, p = 2.9×10 -27 ) compared to all other CpGs. 54.5% of CpGs including 48.5% of overlap CpGs were modified by meQTLs, while 94.6% of overlap probes were affected by eQTLs.
35.7% of meQTLs were also cis-eQTLs in regulating the gene expression of the module.
Based on the ExpRep1 and MethyRep2 datasets assayed from the same subjects, we tested the associations between expression probes and their nearby (<500kbps) CpGs from each of the above overlapping sets. There were only few expression-methylation pairs (1.2~8.9%) matched due to lower resolution in MethyRep2. After controlling for covariates age, sex and PMI, 20%, 25% and 47.8% of matched pairs showed significant associations (FDR<0.05) in yellowExp-yellowMethy, blueExp-blueMethy and blueExp-redMethy links, respectively. 
Discussion
We used large transcriptomics and epigenetics data from human brain frontal cortex to explore the relationship between co-expression and methylation modules in terms of their overlap in genes, associations with SCZ and aging, as well as their shared underlying genetic risk. Our findings were replicated in multiple independent datasets on module's associations with SCZ and age, and module's preservation, and further verified by direct associations between individual CpGs and gene expression probes. We found two modules in each modality showing significant associations with SCZ, and three pairs of overlapping methylation and expression modules related to SCZ or aging.
SCZ-related modules and their expression-methylation relationship
Two co-expression modules were significantly associated with SCZ with one (yellow module)
including the genes more specifically expressed in astrocytes. This module is highly preserved across studies and also in line with the identified modules in previous RNA-sequencing studies of DLPFC tissue [15, 16, 51] , showing consistent pattern with up-regulation of module expression in SCZ compared to HCs. In particular, the genes from the yellow module are also highly enriched in the module (CD4: astrocyte) reported in a recent study of transcription across five psychiatric disorders [51] , which demonstrated significant changes of the module expression in SCZ, autism, and bipolar disorder. Astrocytes are known to be involved in synaptic metabolism and regulation of neurotransmitter release and reuptake (e.g., GABA The yellow methylation module showed a significant association with SCZ. In particular, those methylation target genes included astrocyte highly-affinity glutamate transporters SLC1A2
and SLC1A3 [60], astrocyte-specific expressed marker gene ALDH1L1 [61]. As shown in Fig.S9 (B) and Table S2 (Supplementary file 1), they were also marginally enriched in GABAergic synapse (GABRA1, GABRD, GNAO1, GNG7, PLCL1, PRKCA, CACNA1A) and serotonergic synapse (HTR1B, HTR2A, HTR3B, KCNJ3), which are crucial neurotransmitter pathways in pathogenesis of SCZ [62-64]. Significant down-regulation of DNA methylation in most of CpGs near these genes (partial R 2 = 1.8%~16.1%; Supplementary file 1, Table. S2) in SCZ, along with significant enrichment of module genes in growth development and neurogenesis, suggests the potential role of epigenetics in regulating glia cell function via these neurotransmitter signaling pathways. This is in agreement with previous findings of astrocyte epigenetic regulation in the pathophysiology of psychiatric disorders [54, 65, 66 ]. In addition, the genes nearby CpGs in the module were more likely to be mapped to PGC SCZ risk regions (p = 0.057) than the genes from the other methylation modules. In particular for SCZ high risk genes
(Supplementary file 1, Table S1 ) including RERE, MAD1L1, FURIN, GATAD2A, they have been reported to show significant methylation level alterations in SCZ from previous DNA methylation genome-wide association studies [67] [68] [69] .
The significant overlap between the yellow expression and the yellow methylation modules mainly involves genes with functions in some metabolic processes, biosynthetic process and fatty acid oxidation, which demonstrated the potential relationship with nervous system development in previous studies [61, 70] . In particular, CpGs nearby genes SLC1A2, SLC1A3
and PRKCA from glutamate synapse showed hypo-methylation in SCZ which may lead to upregulated expressions of these genes in astrocyte of SCZ, consistent with our results as shown in Table. S1 (Supplementary file 1). Significantly, a higher percentage of CpGs in the module were enriched in CGI shores which is known to be variable, compared the CpGs from the other modules. In addition, cis-eQTLs were identified for a large proportion of genes and enriched for SCZ and other three psychiatric disorders risk loci. These results suggest combinatorial effects of genetic and epigenetic components in regulating gene expression in astrocytes, dysregulation of which is associated with SCZ.
Aging-related modules and their expression-methylation relationship
The module genes from blue expression module were highly enriched in genes expressed in oligodendrocytes, which are the CNS cells involved in myelination [71, 72] . GO enrichment test further validated that the functions of those specifically expressed module genes mainly involved oligodendrocytes differentiation, gliogenesis and development, ensheathment and myelination, which have been reported to be critical in maintenance of white matter integrity and structural connectivity in central nervous system [73, 74] . We found down-regulation of module expression, especially of the oligodendrocyte OLIG2 gene (t = -2.56, p = 0.01) along with increase of age. OLIG2 can promote the formation of oligodendrocyte precursors and oligodendrocyte differentiation. Lower expression of OLIG2 may cause deficits in oligodendrocyte production and differentiation and thus affect the formation of myelin, which is potentially related to the decreased ability of remyelination in the aging brain [75] . Although marginal association with SCZ was found in the first module eigengene, previous studies have shown the lower level of oligodendrocyte-associate gene expression in frontal cortex of SCZ along with myelination impairment and cognitive loss [6, 76] . Given that a number of studies have shown the dramatic loss of structural connectivity and white matter integrity across the brain regions in SCZ, it is promising to probe the role of oligodendrocytes-related expression module in the development of SCZ. In addition, the module harbored 13% SCZ risk genes and their cis-eQTLs were significantly enriched in most of psychiatric disorders risk loci, suggesting the potential pathology of genetic risk in SCZ through the alteration of module expression in oligodendrocytes. Table S3 ) in the blue module.
CpGs nearby genes MYRF, MBP and MAG also showed significant decreases (partial R 2 = 9%~39%; Supplementary file Table S3 ) along with the increase of age in the red methylation module. Additional pathway analyses showed that those myelin related genes together with many other genes in the modules were enriched for several functional pathways including central nervous development, neurogenesis, and glia cell differentiation, suggesting the potential of epigenetic regulations of these pathways in altering the oligodendrocyte differentiation and myelinations during aging process [79] .
Functional pathways related to oligodendrocyte development and differentiation were shared by both expression and methylation modules, leading to significant overlap between the modules. There was a significant proportion of CpGs (20.9~41.3%) located nearby TSS of expression module genes (<5kbp), mostly enriched in gene body and enhancer regions, suggesting the regulation effect of those methylation module in expression modules [29] . In particular, by the association tests on the methylation and gene expression from the same subjects, we identified 25~47.8% of matched expression-methylation pairs mainly showing significant negative associations (Supplementary file 1, Table S4 ), including some oligodendrocyte highly associated genes MYRF, MAG and SOX10. Enrichment tests on neural specific methylation patterns showed that both methylation modules were enriched for hypomethylation in glia cells compared to neurons, which might potentially contribute to their associated gene expression specificity in oligodendrocytes. These further evidences suggest epigenetic regulation on gene expression in oligodendrocytes to change myelination process.
Genetics was also found to have large effects on both methylation and expression modules. A majority of module gene expressions were regulated by cis-eQTLs (74%~95%) and a relative high proportion of CpGs (40.2~54.5%) from both methylation modules were significantly regulated by cis-meQTLs. Especially, 35.7~46.2% meQTLs modifying overlap CpGs were also cis-eQTLs, indicating a pathway of some genetics in regulating oligodendrocyte gene expression through epigenetics. This genetic, epigenetic and expression interplay is in line with our previous knowledge of both gene and environmental factors involved in the process of demyelination during aging [80] . In addition, we found significant enrichment of cis-eQTLs in psychiatric disorders' risk loci, which suggests shared genetics between risk for psychiatric disorders and regulating aging process which alter gene expression of oligodendrocytes, and partially reflect the similar decreases of myelination in both aging and SCZ patients.
To sum up, using a network analysis focused on DLPFC postmortem tissues, we identified and replicated two expression and two methylation modules significantly associated with SCZ with one pair showing significant overlap and enrichment in astrocyte-associated functional pathways. Additional overlapped expression-methylation module pairs were also replicated in relation to aging process with module genes mostly involved in oligodendrocyte development and myelination. Further examination of underlying QTLs showed the significant enrichment of eQTLs in most of psychiatric disorders' risk loci, but not for meQTLs, suggesting combinatorial effects of genetics and epigenetics in regulating gene expression in glia cells of psychiatric disorders. This work as proof-of-concept demonstrates the existence of coherence between gene expression and DNA methylation at the network level, and provides support for the critical role of epigenetics in glial cell development and function during aging process and psychosis development.
Limitations
The findings of this study should be interpreted in consideration of several limitations. Firstly, the analysis was performed on the datasets from different studies of different cohorts. Tests on the associations between methylation and expression from the same cohorts are still waiting for more efforts in psychiatric genetics research field. Although we tried to validate our findings in a study with both datasets, lower resolution of methylation array and missing of psychosis information limit our knowledge of the broad relationship between two features. Secondly, we have removed effects of some covariates (e.g., RNA quality, PMI, cell type and batch) prior network construction, but the modules may still be sensitive to the other factors (e.g., disease status and medication) and parameter settings in the method (e.g., block size and power index).
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